Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Marion Schroeder

Twelve Per Cent of 6142 Eyes Treated for Neovascular Age‐related Macular Degeneration (nAMD) Presented With Low Visual Outcome Within 2 Years. Analysis From the Swedish Macula Registry (SMR)

Acta Ophthalmologica
MedicineOphthalmology
2019English

No Improvement in Injection Frequency or in Visual Outcome Over Time in Two Cohorts of Patients From the Same Swedish County Treated for Wet Age-Related Macular Degeneration

Clinical Ophthalmology
Ophthalmology
2017English

Related publications

Treatment for Neovascular Age-Related Macular Degeneration in Sweden: Outcomes at Seven Years in the Swedish Macula Register

Acta Ophthalmologica
MedicineOphthalmology
2017English

Aflibercept Improves Outcome in Eyes With Poor Vision From Neovascular Age-Related Macular Degeneration

Acta Ophthalmologica
MedicineOphthalmology
2016English

Visual Outcomes in Patients With Neovascular Age-Related Macular Degeneration

Acta Ophthalmologica
MedicineOphthalmology
2017English

Functional and Anatomical Outcome of Eyes With Neovascular Age-Related Macular Degeneration Treated With Intravitreal Ranibizumab Following an Exit Strategy Regimen

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2014English

Aflibercept for Neovascular Age-Related Macular Degeneration

Cochrane Database of Systematic Reviews
2016English

Characteristics of Eyes With Secondary Loss of Visual Acuity Receiving Variable Dosing Ranibizumab for Neovascular Age-Related Macular Degeneration

Graefe's Archive for Clinical and Experimental Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2011English

Macular Atrophy in Neovascular Age Related Macular Degeneration

Journal of Clinical Review & Case Reports
2019English

Assessing the Accuracy of a Large Observational Registry of Neovascular Age-Related Macular Degeneration

Retina
MedicineOphthalmology
2020English

Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration in Patients Aged 90 Years or Older: 2-Year Visual Acuity Outcomes

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy